Establishing evidence for change in ovarian cancer surgery - Proposing clinical trials of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer peritoneal carcinomatosis

被引：11
作者：
Chua, Terence C. [1 ]
Liauw, Winston [2 ]
Robertson, Greg [3 ]
Morris, David L. [1 ,4 ]
机构：
[1] Univ New S Wales, Dept Surg, St George Hosp, Sydney, NSW 2217, Australia
[2] St George Hosp, Dept Med Oncol, Sydney, NSW, Australia
[3] St George Hosp, Dept Gynaecol Oncol, Sydney, NSW, Australia
[4] King Fahad Med City, Riyadh, Saudi Arabia
来源：
GYNECOLOGIC ONCOLOGY | 2009年 / 115卷 / 01期
关键词：
SURVIVAL; EFFICACY; METAANALYSIS; PACLITAXEL; CISPLATIN;
D O I：
10.1016/j.ygyno.2009.06.010
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：166 / 168
页数：3
相关论文
共 20 条
[1]   Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer [J].
Alberts, DS ;
Liu, PY ;
Hannigan, EV ;
OToole, R ;
Williams, SD ;
Young, JA ;
Franklin, EW ;
ClarkePearson, DL ;
Malviya, VK ;
DuBeshter, B ;
Adelson, MD ;
Hoskins, WJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (26) :1950-1955
[2]   Intraperitoneal cisplatin and paclitaxel in ovarian cancer [J].
Armstrong, DK ;
Bundy, B ;
Wenzel, L ;
Huang, HQ ;
Baergen, R ;
Lele, S ;
Copeland, LJ ;
Walker, JL ;
Burger, RA .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (01) :34-43
[3]   Treatment of ovarian cancer with paclitaxel- or carboplatin-based intraperitoneal hyperthermic chemotherapy during secondary surgery [J].
Bae, Jeong Hoon ;
Lee, Joon Mo ;
Ryu, Ki Sung ;
Lee, Yong Seok ;
Park, Yong Gyu ;
Hur, Soo Young ;
Ahn, Woong Shik ;
Namkoong, Seong Eun .
GYNECOLOGIC ONCOLOGY, 2007, 106 (01) :193-200
[4]  
BEREDER JM, 2008, 6 WORKSH PER SURF ON
[5]   Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis [J].
Bristow, RE ;
Tomacruz, RS ;
Armstrong, DK ;
Trimble, EL ;
Montz, FJ .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (05) :1248-1259
[6]   Cytoreductive surgery for recurrent ovarian cancer: A meta-analysis [J].
Bristow, Robert E. ;
Puri, Isha ;
Chi, Dennis S. .
GYNECOLOGIC ONCOLOGY, 2009, 112 (01) :265-274
[7]  
CHI DS, 2009, GYNECOL ONCOL
[8]  
CHUA TC, 2009, GYNECOL ONCOL
[9]   Should the Treatment of Peritoneal Carcinomatosis by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Still be Regarded as a Highly Morbid Procedure? A Systematic Review of Morbidity and Mortality [J].
Chua, Terence C. ;
Yan, Tristan D. ;
Saxena, Akshat ;
Morris, David L. .
ANNALS OF SURGERY, 2009, 249 (06) :900-907
[10]   Critique of surgical cytoreduction in advanced ovarian cancer [J].
Covens, AL .
GYNECOLOGIC ONCOLOGY, 2000, 78 (03) :269-274
12